NCT07588438: Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.
- State
- Under way
- Phase
- Phase 4
- People
- 160 planned
- Started
- 27 Jul 2026
- Primary completion
- 10 Aug 2027
- Arms
- Cohort 1: Obesity Without T2DM, Cohort 2: T2DM With or Without Obesity
- Results
- None posted
- 14 May 2026: Trial registered